Biobank Consumables Market: Market Size & Forecast 2026

Biobank consumables are the disposable items that sit at the front line of every repository of human, animal, or microbial samples, from blood-collection tubes and cryovials to nucleic-acid extraction kits and labelling consumables. The category is closely tied to, but distinct from, the broader biobanking market, because it excludes capital equipment such as freezers, robotics, and information systems. With a 2025 valuation near $7.81 billion and a 9.1% compound annual growth rate, the segment is one of the faster-growing pockets of the life-science supplies industry.

• •Market size in 2025 is approximately $7.81 billion, with a 9.1% CAGR through 2030.
• •Product scope spans sample collection containers, storage tubes, and sample preparation and analysis kits.
• •Demand is anchored by clinical, academic, and population-scale biorepositories worldwide.

The principal engine is the surge in genomics, precision medicine, and large longitudinal cohort studies, all of which depend on high-quality, well-annotated specimens. Public funding for cancer genomics, infectious-disease surveillance, and rare-disease research is pushing repositories to standardize on premium, traceable consumables, while biobanks themselves are scaling up storage capacity. At the same time, cell and gene therapy development is creating a parallel demand pull for cryogenic storage consumables and validated sample-preparation kits.

• •Rising investment in personalized medicine and large-scale genomics projects is boosting specimen volumes.
• •Expansion of cell, gene, and cell-based therapy pipelines is increasing demand for cryogenic storage consumables.
• •Stricter sample-quality, chain-of-custody, and regulatory standards are shifting purchasing toward higher-grade consumables.

By product type, sample collection containers and sample storage tubes account for the largest share of revenue, while sample preparation and analysis kits are the fastest-growing sub-segment as biobanks internalize more processing. By end user, demand is split across academic and research biobanks, hospital and clinical biorepositories, and commercial biorepositories serving pharma and biotech. Geographically, North America leads on the back of well-funded programs such as the All of Us Research Program, while Europe follows closely, and Asia-Pacific is the fastest-growing region as China, Japan, South Korea, and India build out national biobanking infrastructure.

• •Sample collection containers and storage tubes dominate revenue; preparation kits are growing the fastest.
• •North America holds the leading share, with Europe second and Asia-Pacific the highest-growth region.
• •Academic, hospital-based, and commercial biorepositories each represent meaningful demand centers.

What are the recent trends and outlook?

Automation is reshaping the consumables market, as biobanks move toward robotic storage and retrieval systems that require barcoded, dimensionally standardized tubes and plates. Sustainability is also gaining traction, with vendors introducing lower-plastic, recyclable, and energy-efficient cold-chain packaging in response to ESG targets. Looking ahead, expect continued double-digit growth in Asia-Pacific, deeper integration of consumables with laboratory information management systems, and rising demand for kits purpose-built for liquid biopsy, single-cell, and microbiome applications.

• •Automation-ready, barcoded consumables are becoming the default in new and retrofitted biobanks.
• •Sustainability initiatives are pushing vendors toward recyclable plastics and greener cold-chain packaging.
• •Fast-growing applications such as liquid biopsy, single-cell, and microbiome research are driving kit innovation.